This test is most useful if any of these apply to you.
If you live in a region with olive trees or related plants like ash, privet, or lilac, and you suffer from seasonal sneezing, itchy eyes, or asthma flares, this test can tell you whether olive pollen is genuinely the culprit. A standard skin prick test can light up positive for olive pollen even when the real driver is a different tree, because pollen proteins from related plants look similar to your immune system.
This test measures Ole e 1 (the main allergy-triggering protein from olive pollen) IgE in your blood. A positive result means your immune system has made antibodies specifically against this protein, marking you as truly sensitized to olive or its botanical cousins, rather than reacting to a look-alike protein from another plant.
Olive pollen is a complex mix of proteins, but Ole e 1 is the dominant one. It affects more than 70% of people sensitized to olive pollen and is what scientists call a marker allergen, meaning a positive result genuinely points to olive tree pollen exposure as the trigger. The protein is released from olive pollen grains into the air during the spring blooming season and lands on your nasal lining, where it can bind to immune cells and set off the cascade that produces runny nose, watery eyes, and wheezing.
Ole e 1 shares significant structural similarity with the major allergens of other plants in the same family (called Oleaceae), including ash, privet, lilac, and forsythia. That overlap means a positive Ole e 1 result can also indicate sensitization to these related trees, which is useful in regions where olive is not commonly planted but other Oleaceae are widespread.
Ole e 1 is the antibody pattern most closely linked to the classic respiratory form of olive pollen allergy. In a study of olive-allergic patients, those positive for Ole e 1 mainly had seasonal rhinitis, conjunctivitis, and asthma, while patients reactive to other olive components like Ole e 7 had more food and systemic reactions. A positive Ole e 1 result therefore identifies the respiratory phenotype of olive allergy.
Real-world exposure data backs this up. Studies tracking airborne olive pollen and Ole e 1 protein concentrations in Spain found that higher levels correlate with worse rhinitis and asthma symptoms in sensitized people. In adult asthma patients enrolled in a large molecular profiling study (the LEAD cohort), olive family allergens including Ole e 1 were among the most common outdoor sensitizers identified.
Sensitization patterns vary by geography. In a French cohort, about one in five participants had measurable IgE against Ole e 1. In two regions of Germany where olive trees are rare, a majority of people who reacted to olive on skin testing but not to ash had Ole e 1 antibodies in their blood, likely reflecting travel exposure or reactions to local Oleaceae like ash and privet. Sensitization is highest in olive-growing regions of southern Europe but is being increasingly reported in northern Europe as climate patterns shift.
A standard skin prick test for olive pollen extract is sensitive but not very specific. Pollen extracts contain dozens of proteins, and many of them cross-react with proteins from grasses, weeds, and unrelated trees. This is why a skin test can read positive for olive pollen even when olive is not the true driver of your symptoms. Measuring blood IgE to the specific Ole e 1 protein gives you a much cleaner answer about whether the olive family is really involved.
This distinction matters when planning treatment. In a Spanish study of children sensitized to both grass and olive pollen, adding molecular component testing including Ole e 1 changed the prescribed allergen immunotherapy in about half of cases. A similar pattern appeared in a study of adult polysensitized patients in Catalonia, where molecular profiling significantly improved which allergen extract was chosen for immunotherapy.
Certain immune system genes are linked to a higher chance of developing IgE antibodies against olive pollen. Specific variants of HLA class II genes (a family of immune recognition genes) have been associated with Ole e 1 sensitization in adult cohorts. This does not mean genetic testing replaces measuring Ole e 1 directly, but it helps explain why some people exposed to olive pollen develop strong allergic responses while others do not.
A single Ole e 1 result is a starting point, not a final verdict. Sensitization patterns can shift over time, and the clinical importance of a positive result depends on whether you are getting better, staying the same, or worsening over multiple pollen seasons. If you are pursuing allergen immunotherapy, retesting at intervals helps gauge whether your immune response is changing in the way the treatment intends.
For someone newly diagnosed, a reasonable approach is to get a baseline test, retest after a full pollen season or after starting immunotherapy, and then check annually. Pairing the trend with a symptom diary kept during the olive pollen season (typically spring in the Northern Hemisphere) gives the most useful picture, because the number alone does not predict severity without context.
A positive Ole e 1 result confirms sensitization but does not guarantee you will have clinical symptoms. Some people carry IgE antibodies without ever feeling unwell during pollen season. Conversely, a negative result for Ole e 1 does not rule out allergy to other olive pollen proteins like Ole e 7 or Ole e 9, which define different clinical subsets of olive allergy.
Two analytical issues are worth flagging. First, different testing platforms (ImmunoCAP, ALEX, ISAC) can produce slightly different numbers for the same sample, so trending is most meaningful when the same method is used across visits. Second, very high total IgE from any cause can make some allergen-specific results harder to interpret without expert review.
A surprise positive Ole e 1 in someone without symptoms is not a reason to start treatment. It is a reason to watch for symptoms during the next olive or ash pollen season and to consider environmental controls if symptoms appear. A positive result in someone with active rhinitis or asthma is a stronger signal and warrants a conversation with an allergist about whether olive pollen immunotherapy or related interventions are appropriate.
If your result is positive and your symptoms are severe or affect your quality of life, the next steps typically include broader component-resolved testing to check for other olive proteins and cross-reactive panallergens, a careful symptom history mapped to the local pollen calendar, and a discussion with an allergist about whether sublingual or subcutaneous immunotherapy is a fit. Skin prick testing with whole extracts is often used alongside component IgE to confirm clinical relevance.
Evidence-backed interventions that affect your Olive (Ole e 1) IgE level
Olive (Ole e 1) IgE is best interpreted alongside these tests.